Delivery Order HHSD200200100081I-HHSD2002001000810023

This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services. The $296,882.69 contract is for a "NATIONAL STUDY EARLY DIAG OF TB IN AFRICAN AMERICAN COMMUNITY" and has a September 28, 2011 completion date. The contract is a Delivery Order with a Cost No Fee pricing type and does not have a set-aside designation. Emory University, through its Office of...

Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...

The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....

The Centers for Disease Control and Prevention (CDC) Pittsburgh division awarded a $10.67 million cost-reimbursable contract to King County's Public Health-Seattle & King County division on January 1, 2021, with a completion date of December 31, 2030. This definitive contract, awarded competitively with no set-aside designation, supports tuberculosis clinical trials and consortium services. The primary deliverables include participation in clinical research studies, adherence to study...

This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...

This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Nues, Inc., a Small Business Administration certified Economically Disadvantaged Women-Owned Small Business and 8(a) Program Participant. The $98,420.63 contract is for on-site monitoring services to support the Tuberculosis Trials Consortium (TBTC) Study 35, a Phase I/II dose-finding and safety study of rifapentine and isoniazid in HIV-infected and HIV-uninfected children with latent...

The Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $3.78M to Denver Health and Hospital Authority for tuberculosis trials and consortium services. The contract, effective January 1, 2021, and extending through December 31, 2030, supports clinical research activities under the CDC's broader tuberculosis prevention and treatment initiatives. Denver Health will serve as a participating site in the Tuberculosis Trials Consortium, conducting...

This is a $177,449.73 Firm Fixed Price Delivery Order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Tougaloo College, a private Historically Black College and University (HBCU). The award provides a diversity supplement to Waynesha Blaylock for the Jackson Heart Study (JHS) Training and Education Center (TEC). The Jackson Heart Study is a major research program focused on cardiovascular disease in African American populations. Tougaloo College, as an HBCU, plays a...

The Medical University of South Carolina (MUSC) was awarded a cost-reimbursable, definitive contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh office on January 1, 2021, to support clinical research services for the Tuberculosis Trials and Consortium. The contract has a ceiling value of $9.86 million and extends through December 31, 2030, with performance conducted in South Africa. This award emerged from a pre-solicitation notice issued in February 2020 seeking clinical...

This is a $445,000.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Cape Town (UCT) in South Africa. The contract supports the PREDICT-TB and NEXGEN clinical trials, which are focused on tuberculosis research and development. UCT, a major research institution in South Africa, has extensive expertise in infectious disease research and...